Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
We propose the development of tools that can help identify cognitively normal subjects at risk for developing Alzheimer’s Disease (AD). The tests will use small volumes of peripheral fluids (blood, saliva, urine). Our goal is to evaluate the potential of exosomes to be used as “carriers of AD biomarkers”. These markers will be essential for the assessment of susceptibility/risk for AD. We also propose to identify and develop technologies for the detection of exosomes and the AD markers they contain. Exosome isolation techniques, plasmonic-based biosensor technologies, and novel optical microscopy tools will be developed and used.
Sebastian Wachsmann-Hogiu
VIS Technology
Engineering
Health and Related Sciences & Technology; Biotechnology; Nanotechnology
McGill University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.